Healthy prospects are expected in the future when it comes to real estate in Pakistan.

Real estate follows the perception of being one of the safest investment streams in struggling economies such as Pakistan.

Investors usually follow the safe pattern, expecting reasonable returns with the return of the principal amount invested.

Although investment is expected to be impaired by current and prospective inflationary trends in Pakistan, after the temporary phase of inflation gets over, the situation will be much favorable.

Duration of return and yield on investment are expected to remain the same in the coming period.

It may follow some stagnation due to economic issues but it will no longer be prevailing once the issues have vanished.

The real estate market has witnessed much significant bloom as compared to past years.

Investors are showing confidence in the real estate market, as well as the magnitude of transactions, has also significantly increased.

Many willful buyers of the property have also been ascended.

If we benchmark the real estate market based on the following factors

Quantum of investment

Although the quantum of required funds required to be invested in a real estate project has increased in amount or numbers, the percentage of funds required for property investment is yet not jumped so far.

The increase in the amount of investment has increased largely because of the upward inflationary trend prevailing in the economy taken as a whole.

Rate of Return

The rate of return on real estate or yield of investment has been increased as compared to the past years. The real rate of return is a quite consistent year by year.

Time of return

The time of return is not an absolute factor to be considered, it varies from project to project. On an average basis, the time of return has been the same that it used to be in earlier years in the case of long-term investments.

However, in short-term investments, where investors are interested in smaller yet frequent yields it has shown positive results overall.